Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
Ewa Galaj, Zheng‐Xiong Xi
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 134-134
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 975-975
Open Access | Times Cited: 45
Pharmacological effects of cannabidiol by transient receptor potential channels
Leila Etemad, Gholamreza Karimi, Mohaddeseh Sadat Alavi, et al.
Life Sciences (2022) Vol. 300, pp. 120582-120582
Closed Access | Times Cited: 45
Review of the oral toxicity of cannabidiol (CBD)
Jeremy Gingrich, Supratim Choudhuri, Patrick Cournoyer, et al.
Food and Chemical Toxicology (2023) Vol. 176, pp. 113799-113799
Open Access | Times Cited: 25
Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1
Adriana Yndart, Nagesh Kolishetti, Arti Vashist, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Multifaceted targets of cannabidiol in epilepsy: Modulating glutamate signaling and beyond
Pukar Khanal, Vishal S. Patil, Kunal Bhattacharya, et al.
Computers in Biology and Medicine (2024) Vol. 179, pp. 108898-108898
Closed Access | Times Cited: 6
Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation
Berhanu Geresu Kibret, Ana Canseco-Alba, Emmanuel S. Onaivi, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 17
Open Access | Times Cited: 14
Involvement of D2-like dopamine receptors within the ventral tegmental area in the cannabidiol's inhibitory effects on the methamphetamine-seeking behavior
Mohammad Javad Ezzati, Mohammad Ezzati, Mojdeh Fattahi, et al.
Physiology & Behavior (2025), pp. 114845-114845
Closed Access
Psychostimulant and opioid abuse: A perspective from Uruguay
Analía Richeri, R. L. McGregor, Cecilia Scorza
Neuroscience (2025)
Closed Access
Epidemiology and Health Impacts of Substance Use
Richard Alecsander Reichert, Flávia Zacouteguy Boos, Fernanda Machado Lopes, et al.
(2025), pp. 87-119
Closed Access
Cannabidiol Protects against the Reinstatement of Oxycodone-Induced Conditioned Place Preference in Adolescent Male but Not Female Rats: The Role of MOR and CB1R
Justyna Socha, Paweł Grochecki, Marta Marszałek‐Grabska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6651-6651
Open Access | Times Cited: 4
Cannabis-Based Phytocannabinoids: Overview, Mechanism of Action, Therapeutic Application, Production, and Affecting Environmental Factors
Marta Jurga, Anna Jurga, Kacper Jurga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11258-11258
Open Access | Times Cited: 4
Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking adolescent rats. Focus on calcitonin gene‐related peptide's brain levels
Giuseppe Tringali, Gianluca Lavanco, Valentina Castelli, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 4870-4884
Open Access | Times Cited: 9
An Overview of Cannabidiol
Alexandra Sideris, Lisa Doan
Anesthesia & Analgesia (2023) Vol. 138, Iss. 1, pp. 54-68
Open Access | Times Cited: 9
Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview
Iqra Kalsoom, Kiran Shehzadi, Hansheng Li, et al.
Topics in Current Chemistry (2024) Vol. 382, Iss. 2
Closed Access | Times Cited: 3
CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice
Miguel Á. Luján, Laia Alegre-Zurano, Ana Martín‐Sánchez, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 113, pp. 110462-110462
Open Access | Times Cited: 22
Cannabidiol decreases motivation for cocaine in a behavioral economics paradigm but does not prevent incubation of craving in mice
Laia Alegre-Zurano, Paula Berbegal-Sáez, Miguel Á. Luján, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112708-112708
Open Access | Times Cited: 14
Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond
Briana J. Hempel, Zheng‐Xiong Xi
Advances in pharmacology (2022), pp. 275-333
Open Access | Times Cited: 14
β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms
Xianghu He, Ewa Galaj, Guo‐Hua Bi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 18
Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network
Francesca Mottarlini, Marco Fumagalli, Fernando Castillo Díaz, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1853-1853
Open Access | Times Cited: 13
Hippocampal D1-like dopamine receptor as a novel target for the effect of cannabidiol on extinction and reinstatement of methamphetamine-induced CPP
Amir Mohammad Farrokhi, Fazel Moshrefi, Kiarash Eskandari, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111025-111025
Closed Access | Times Cited: 2
Cannabigerol modulates α2-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat
Aitziber Mendiguren, Erik Aostri, Irati Rodilla, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Toxicological safety assessment of HempChoice® hemp oil extract; a proprietary extract consisting of a high concentration of cannabidiol (CBD) in addition to other phytocannabinoids and terpenes derived from Cannabis sativaL
Margitta Dziwenka, Robert W. Coppock, Michael Davidson, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16913-e16913
Open Access | Times Cited: 6
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic
Júlia Cozar Pacheco, José Diogo S. Souza, Jaime E. C. Hallak, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 3, pp. 327-329
Closed Access | Times Cited: 14
Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
Kristine Rømer Thomsen, Birgitte Thylstrup, Emily A. Kenyon, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 169-180
Open Access | Times Cited: 13
Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents
Bryan W. Jenkins, Shoshana Buckhalter, Melissa L. Perreault, et al.
Schizophrenia Bulletin Open (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top